Aspira Pathlab & Diagnostics (BOM:540788) Scaled Net Operating Assets: N/A (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540788 Aspira Pathlab & Diagnostics Ltd BOM:540788
51 GF Score
Price ₹106.90
GF Value ₹70.73
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Aspira Pathlab & Diagnostics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aspira Pathlab & Diagnostics's operating assets for the quarter that ended in Mar. 2026 was ₹168.0 Mil. Aspira Pathlab & Diagnostics's operating liabilities for the quarter that ended in Mar. 2026 was ₹29.5 Mil. Aspira Pathlab & Diagnostics's Total Assets for the quarter that ended in Dec. 2025 was ₹0.0 Mil. Therefore, Aspira Pathlab & Diagnostics's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was N/A.

Aspira Pathlab & Diagnostics Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Aspira Pathlab & Diagnostics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspira Pathlab & Diagnostics Scaled Net Operating Assets Chart

Aspira Pathlab & Diagnostics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.21 0.70 0.60 0.82 0.79

Aspira Pathlab & Diagnostics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:540788 vs TMO, DHR, IDXX: Scaled Net Operating Assets Comparison

For the Diagnostics & Research subindustry, Aspira Pathlab & Diagnostics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aspira Pathlab & Diagnostics Scaled Net Operating Assets vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Pathlab & Diagnostics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Aspira Pathlab & Diagnostics's Scaled Net Operating Assets falls into.


BOM:540788
51GF Score
Aspira Pathlab & Diagnostics Ltd BOM:540788
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspira Pathlab & Diagnostics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aspira Pathlab & Diagnostics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2026 )
=(Operating Assets (A: Mar. 2026 )-Operating Liabilities (A: Mar. 2026 ))/Total Assets (A: Mar. 2025 )
=(168.012-29.524)/174.615
=0.79

where

Operating Assets(A: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=185.057 - 17.045
=168.012

Operating Liabilities(A: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=62.747 - 24.447 - 8.776
=29.524

Aspira Pathlab & Diagnostics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(168.012-29.524)/0
=N/A

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=185.057 - 17.045
=168.012

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=62.747 - 24.447 - 8.776
=29.524

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Aspira Pathlab & Diagnostics (BOM:540788) Overvalued in 2026?

Based on GuruFocus' analysis, Aspira Pathlab & Diagnostics stock appears to be overvalued. The current stock price of ₹106.90 is trading 51.1% above its estimated GF Value™ of ₹70.73. GuruFocus considers Aspira Pathlab & Diagnostics to be Significantly Overvalued.

Key valuation signals for BOM:540788:

  • Scaled Net Operating Assets: N/A
  • GF Value™: ₹70.73 vs. price of ₹106.90 (51.1% above fair value)
  • GF Score™: 51/100 with 1 warning sign

No single metric tells the full story. See the BOM:540788 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspira Pathlab & Diagnostics Business Description

Address 6 & 7, Bhaveshwar Arcade, Near Shreyas Junction LBS Marg, Behind Saraswat Bank, Ghatkopar (west), Mumbai, MH, IND, 400086
Aspira Pathlab & Diagnostics Ltd is mainly engaged in pathology and related healthcare services. It operates laboratories that conduct a wide range of pathological investigations across branches such as biochemistry, hematology, histopathology, microbiology, immunochemistry, immunology, virology, cytology, and other pathological and radiological tests. The services offered include pathology tests, sonography, X-rays, and radiology. The company also provides various health packages like gynecology profiles, anemia profiles, monsoon profiles, coagulation tests, cancer screening packages, newborn screening and IEM panels, orthopedic profiles, allergy panels, and cardiac profiles. These comprehensive diagnostic services assist in disease diagnosis.
51GF Score

Get the complete analysis for BOM:540788

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹106.90
Price
₹70.73
GF Value